Intelligent Bio Solutions (INBS) Cash & Equivalents (2021 - 2024)
Historic Cash & Equivalents for Intelligent Bio Solutions (INBS) over the last 4 years, with Q1 2024 value amounting to $9.4 million.
- Intelligent Bio Solutions' Cash & Equivalents rose 31207.37% to $9.4 million in Q1 2024 from the same period last year, while for Mar 2024 it was $9.4 million, marking a year-over-year increase of 31207.37%. This contributed to the annual value of $8.2 million for FY2022, which is 3447.98% down from last year.
- Per Intelligent Bio Solutions' latest filing, its Cash & Equivalents stood at $9.4 million for Q1 2024, which was up 31207.37% from $1.1 million recorded in Q4 2023.
- Over the past 5 years, Intelligent Bio Solutions' Cash & Equivalents peaked at $14.3 million during Q1 2021, and registered a low of $186401.0 during Q3 2023.
- Over the past 4 years, Intelligent Bio Solutions' median Cash & Equivalents value was $8.2 million (recorded in 2022), while the average stood at $7.3 million.
- As far as peak fluctuations go, Intelligent Bio Solutions' Cash & Equivalents plummeted by 9675.41% in 2023, and later surged by 31207.37% in 2024.
- Intelligent Bio Solutions' Cash & Equivalents (Quarter) stood at $12.6 million in 2021, then tumbled by 76.91% to $2.9 million in 2022, then plummeted by 61.57% to $1.1 million in 2023, then soared by 739.81% to $9.4 million in 2024.
- Its last three reported values are $9.4 million in Q1 2024, $1.1 million for Q4 2023, and $186401.0 during Q3 2023.